FibroBiologics Secures Australian Patent for Breakthrough Cartilage Regeneration Method

FibroBiologics, , a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of therapeutics and potential...

April 12, 2024 | Friday | News
Australian Biotech Firm Ferronova Initiates Clinical Trial for FerroTrace® Nanoparticle Technology in Gastric and Oesophageal Cancers

Australian biotech company Ferronova has announced the initiation of a clinical trial of the company’s FerroTrace® nanoparticle technology in pat...

April 10, 2024 | Wednesday | News
Align Technology Launches Invisalign® Palatal Expander System in Australia and New Zealand

Invisalign® Palatal Expanders offer doctors an effective and easily removable alternative to traditional palatal expanders, without the need for meta...

April 02, 2024 | Tuesday | News
Australia's Telix Pharmaceuticals Forges Alliance to Drive Personalized Cancer Treatment

Telix Pharmaceuticals Limited (ASX: TLX) has announced a strategic agreement to partner with ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaf...

March 19, 2024 | Tuesday | News
Fennec and Norgine Partner to Commercialize PEDMARQSI in Europe, Australia, and NZ

Agreement pairs Norgine’s commercial expertise and leading European footprint with PEDMARQSI®, the first and only approved therapy in the Europea...

March 18, 2024 | Monday | News
Biocon Biologics and Sandoz Australia Forge Partnership for Biosimilars Trastuzumab and Bevacizumab

Biocon Biologics Ltd (BBL), a leading biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), has announced a significant five-ye...

February 09, 2024 | Friday | News
MaxCyte and Imugene Forge Strategic License for Cancer Immunotherapy Advancement

MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, de...

January 23, 2024 | Tuesday | News
ClinChoice Expands Global Presence with Acquisition of CSI in Southeast Asia

ClinChoice further broadens its global footprint and full-service capabilities in more than 30 countries throughout Asia, Europe and North America around t...

January 15, 2024 | Monday | News
First patient has been dosed in Clarity's Phase III trial for Cu-64 SAR-bisPSMA in prostate cancer in Australia

First patient safely dosed in the pivotal Phase III 64Cu-SAR-bisPSMA diagnostic trial, CLARIFY. The aim of the CLARIFY trial is to detect regional nodal...

December 27, 2023 | Wednesday | News
BrainStorm Secures Patents for Allogeneic Exosome Platform in Neurological Disorders

The European Patent office granted patent No. 3105587 titled 'Method of Qualifying of Cells' for a method of qualifying whether a cell population is a suit...

December 27, 2023 | Wednesday | News
Carina Biotech Doses First Australian Patient in LGR5 CAR-T Trial

First patient dosed in Australia where 3 clinical trial sites have been activated. The trial will enrol advanced colorectal cancer patients whose cancer...

December 19, 2023 | Tuesday | News
Parse Biosciences Secures $50M for Global Growth

Parse Biosciences, a leading provider of easily accessible and scalable solutions for single-cell sequencing, announced today that the company has raised $...

December 18, 2023 | Monday | News
Junshi Biosciences' Toripalimab Application Accepted by Australia’s TGA

For the first-line treatment of adults with metastatic or recurrent locally advanced nasopharyngeal carcinoma (NPC), and for toripalimab, as a single agent...

December 04, 2023 | Monday | News
ShiraTronics Launches First-Ever Trial for Chronic Migraine Therapy in Australia.

This development underscores the company's commitment to advancing innovative solutions that provide relief and improved quality of life for the millions o...

November 30, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in